                         SEQUENCE LISTING

<110>  University of Copenhagen
 
<120>  Fatty acid derivatives of dimeric inhibitors of PSD-95

<130>  P3416PC00

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  X is independently any amino acid


<220>
<221>  SITE
<222>  (1)..(4)
<223>  Peptide 1

<220>
<221>  SITE
<222>  (1)..(1)
<223>  X4 in description; amino acid residue selected from E, Q, A, N 
       and S

<220>
<221>  SITE
<222>  (2)..(2)
<223>  X3 in description; amino acid residue selected from S and T

<220>
<221>  SITE
<222>  (3)..(3)
<223>  X2 in description; amino acid residue selected from A, D, E, Q, 
       N, S, V, N-Me-A, N-Me-D, N-Me-E, N-Me-Q, N-Me-N, N-Me-S and 
       N-Me-V

<220>
<221>  SITE
<222>  (4)..(4)
<223>  X1 in description; amino acid residue selected from I, L and V

<400>  1

Xaa Xaa Xaa Xaa 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  X is independently any amino acid


<220>
<221>  SITE
<222>  (1)..(4)
<223>  Peptide 2

<220>
<221>  SITE
<222>  (1)..(1)
<223>  Z4 in description; amino acid residue selected from E, Q, A, N 
       and S

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Z3 in description; amino acid residue selected from S and T

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Z2 in description; amino acid residue selected from A, D, E, Q, 
       N, S, V, N-Me-A, N-Me-D, N-Me-E, N-Me-Q, N-Me-N, N-Me-S and 
       N-Me-V

<220>
<221>  SITE
<222>  (4)..(4)
<223>  Z1 in description; amino acid residue selected from I, L and V

<400>  2

Xaa Xaa Xaa Xaa 
1               


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  specific peptide


<220>
<221>  PEPTIDE
<222>  (1)..(5)
<223>  Specific peptide

<400>  3

Ile Glu Thr Ala Val 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  specific peptide


<220>
<221>  PEPTIDE
<222>  (1)..(5)
<223>  specific peptide

<400>  4

Ile Glu Thr Asp Val 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  X is independently any amino acid


<220>
<221>  SITE
<222>  (1)..(1)
<223>  X5 in description; any amino acid residue

<220>
<221>  SITE
<222>  (2)..(2)
<223>  X4 in description; amino acid residue selected from E, Q, A, N 
       and S

<220>
<221>  SITE
<222>  (3)..(3)
<223>  X3 in description; amino acid residue selected from S and T

<220>
<221>  SITE
<222>  (4)..(4)
<223>  X2 in description; amino acid residue selected from A, D, E, Q, 
       N, S, V, N-Me-A, N-Me-D, N-Me-E, N-Me-Q, N-Me-N, N-Me-S and 
       N-Me-V

<220>
<221>  SITE
<222>  (5)..(5)
<223>  X1 in description; amino acid residue selected from I, L and V

<400>  5

Xaa Xaa Xaa Xaa Xaa 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  X is independently any amino acid


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Z5 in description; any amino acid residue

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Z4 in description; amino acid residue selected from E, Q, A, N 
       and S

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Z3 in description; amino acid residue selected from S and T

<220>
<221>  SITE
<222>  (4)..(4)
<223>  Z2 in description; amino acid residue selected from A, D, E, Q, 
       N, S, V, N-Me-A, N-Me-D, N-Me-E, N-Me-Q, N-Me-N, N-Me-S and 
       N-Me-V

<220>
<221>  SITE
<222>  (5)..(5)
<223>  Z1 in description; amino acid residue selected from I, L and V

<400>  6

Xaa Xaa Xaa Xaa Xaa 
1               5   


